So, is the new "Rapid DNA test/s ...not yet approved by the FDA"
a competition to CST or a complimentary in diagnosis.
I am not clear the way it is written if it is a *TB diagnostic*
e.g.. "...by cutting delays in diagnosis of drug-resistant tuberculosis"
or a *drug resistance detector* for isoniazid and rifampin?
e.g.. "which detects resistance to isoniazid and rifampin."
Can someone clarify?
So, is the new "Rapid DNA test/s ...not yet approved by the...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
